| Date | Time | Source | Headline | Symbol | Company |
| 01/30/2009 | 8:52PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/30/2009 | 4:22PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/30/2009 | 4:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/30/2009 | 2:52PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/30/2009 | 9:20AM | Marketwired | AVI BioPharma, Inc. to Raise $16.5 Million in Registered Direct Offering | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/28/2009 | 9:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/28/2009 | 9:11PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/27/2009 | 10:30AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/21/2009 | 8:00AM | Marketwired | AVI BioPharma Announces Successful Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy by Exon Skipping | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/20/2009 | 5:18PM | Marketwired | AVI BioPharma Announces Conference Call Wednesday, Jan. 21, 2009 to Provide Update on Duchenne Muscular Dystrophy Program | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/12/2009 | 5:10PM | Marketwired | AVI BioPharma and Collaborators Demonstrate In Vivo Effectiveness of PPMO-Based Splice Switching Oligomers (SSOs) in Genetic Dis | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/24/2008 | 9:52AM | Marketwired | BenchmarkJournal.com (Complimentary) Analyst Review for FRED, EXAR, NSANY and AVII | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/23/2008 | 4:22PM | Marketwired | AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents for Treatment of Ebola a | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/23/2008 | 8:00AM | Marketwired | AVI BioPharma Strengthens Its Patent Position in RNA Therapeutics | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/11/2008 | 10:41AM | Marketwired | AVI BioPharma to Present at FDA Public Hearing Regarding Priority Review Vouchers | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/03/2008 | 8:05AM | Marketwired | AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/03/2008 | 8:00AM | Marketwired | AVI BioPharma Files IND for Clinical Trial of Ebola Virus Treatment | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/24/2008 | 8:05AM | Marketwired | AVI BioPharma Strengthens Patent Position in Exon Skipping | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/10/2008 | 8:30AM | Marketwired | AVI BioPharma Announces Third Quarter 2008 Financial Results | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/10/2008 | 8:00AM | Marketwired | AVI BioPharma Announces Initiation of Clinical Trial of Next Generation Drug Eluting Stent by Partner Global Therapeutics | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/10/2008 | 6:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/04/2008 | 8:10AM | Marketwired | AVI BioPharma Announces Third Quarter 2008 Financial Results Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/04/2008 | 8:00AM | Marketwired | AVI BioPharma to Present at Rodman & Renshaw's Annual Global Investment Conference Nov. 11, 2008 | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/31/2008 | 12:12PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/14/2008 | 12:00PM | Marketwired | AVI BioPharma to Co-Host Exon Skipping Conference for Duchenne Muscular Dystrophy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/14/2008 | 9:30AM | Marketwired | AVI BioPharma's Drug for Duchenne Muscular Dystrophy Recommended for Orphan Drug Status in EU and Receiving Provisional GTAC App | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/01/2008 | 12:00PM | Marketwired | AVI BioPharma to Present at the JMP and Maxim Healthcare Conferences | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/22/2008 | 9:30AM | Marketwired | AVI BioPharma to Present at the UBS Global Life Sciences Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/19/2008 | 2:34PM | Edgar (US Regulatory) | Avi Biopharma Inc - Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/08/2008 | 9:30AM | Marketwired | AVI BioPharma to Host Analyst & Investor Breakfast Meeting | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |